foxo4 dri human trial senolytic peptide 2024 FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: Status, Cancer – NAD+ MOTS-C and 5-AMINO-1MQ Catalog No.:M6534-10 Peptide Blend
Pay in 4 interest-free payments of $5.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16